Instituto Rosenbusch Statistics

Total Valuation

BCBA:ROSE has a market cap or net worth of ARS 6.92 billion. The enterprise value is 7.93 billion.

Market Cap	6.92B
Enterprise Value	7.93B

Important Dates

The last earnings date was Wednesday, April 1, 2026.

Earnings Date	Apr 1, 2026
Ex-Dividend Date	n/a

Share Statistics

BCBA:ROSE has 42.59 million shares outstanding.

Current Share Class	42.58M
Shares Outstanding	42.59M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	80.05%
Owned by Institutions (%)	n/a
Float	8.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.08
PB Ratio	-13.15
P/TBV Ratio	n/a
P/FCF Ratio	17.40
P/OCF Ratio	16.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.73
EV / Sales	1.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	19.94

Financial Position

The company has a current ratio of 0.87

Current Ratio	0.87
Quick Ratio	0.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	3.65
Interest Coverage	-2.04

Financial Efficiency

Return on equity (ROE) is -260.63% and return on invested capital (ROIC) is -291.84%.

Return on Equity (ROE)	-260.63%
Return on Assets (ROA)	-23.84%
Return on Invested Capital (ROIC)	-291.84%
Return on Capital Employed (ROCE)	-295.50%
Weighted Average Cost of Capital (WACC)	19.30%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.72
Inventory Turnover	1.99

Taxes

In the past 12 months, BCBA:ROSE has paid 50.87 million in taxes.

Income Tax	50.87M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +84.44% in the last 52 weeks. The beta is 0.04, so BCBA:ROSE's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	+84.44%
50-Day Moving Average	185.29
200-Day Moving Average	195.81
Relative Strength Index (RSI)	46.25
Average Volume (20 Days)	120,955

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BCBA:ROSE had revenue of ARS 6.40 billion and -4.60 billion in losses. Loss per share was -107.95.

Revenue	6.40B
Gross Profit	-286.03M
Operating Income	-3.37B
Pretax Income	-4.46B
Net Income	-4.60B
EBITDA	-3.18B
EBIT	-3.37B
Loss Per Share	-107.95

Full Income Statement

Balance Sheet

The company has 712.26 million in cash and 1.45 billion in debt, giving a net cash position of -737.74 million or -17.32 per share.

Cash & Cash Equivalents	712.26M
Total Debt	1.45B
Net Cash	-737.74M
Net Cash Per Share	-17.32
Equity (Book Value)	-526.19M
Book Value Per Share	-18.79
Working Capital	-872.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 409.89 million and capital expenditures -12.13 million, giving a free cash flow of 397.75 million.

Operating Cash Flow	409.89M
Capital Expenditures	-12.13M
Depreciation & Amortization	192.08M
Net Borrowing	-839.33M
Free Cash Flow	397.75M
FCF Per Share	9.34

Full Cash Flow Statement

Margins

Gross margin is -4.47%, with operating and profit margins of -52.61% and -71.80%.

Gross Margin	-4.47%
Operating Margin	-52.61%
Pretax Margin	-69.70%
Profit Margin	-71.80%
EBITDA Margin	-49.61%
EBIT Margin	-52.61%
FCF Margin	6.21%

Dividends & Yields

BCBA:ROSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-66.43%
FCF Yield	5.75%

Stock Splits

The last stock split was on November 16, 2011. It was a forward split with a ratio of 1.43614361.

Last Split Date	Nov 16, 2011
Split Type	Forward
Split Ratio	1.43614361

Scores

BCBA:ROSE has an Altman Z-Score of -1.83 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.83
Piotroski F-Score	3